Live Updates: U.S. recommends "pause" for Johnson & Johnson COVID vaccine to review blood clot cases
CBSN
The Food and Drug Administration and Centers for Disease Control and Prevention are recommending a "pause" in the administration of Johnson & Johnson's single-dose COVID-19 vaccine to review blood clot cases.
The agencies said in a statement Tuesday the CDC will convene a meeting of the Advisory Committee on Immunization Practices on Wednesday to review six cases of "a rare & severe type of blood clot" in people who received the vaccine. The FDA will then review that analysis as it also investigates the cases. "Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution," Dr. Anne Schuchat, principal deputy director of the CDC, and Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said in the statement.Supreme Court to weigh constitutionality today of anti-camping ordinances in major homelessness case
Washington — The Supreme Court is convening Monday to hear arguments in a dispute over whether laws that ban public camping violate the Constitution's prohibition on cruel and unusual punishment.
Opening statements are set to begin this morning in former President Donald Trump's criminal trial in New York. Prosecutors will begin laying out their case for jurors, alleging Trump falsified business records to cover up a "hush money" payment during his 2016 campaign, while defense attorneys are expected to argue Trump has been charged on flimsy evidence from an untrustworthy key witness.